Gayle Masri Fridling, MD
Dermatology · Vienna, VANPI 1336267681
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,975 of the $4,837 with a category attached, or 61.5%. LEO Pharma Inc. accounts for 65.4% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2024 at $3,562 and has fallen 87.4% since, to $449 in 2025.
Across 44 payments — averaging $109.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LEO Pharma Inc.$3K
- AbbVie$477
- Galderma Laboratories, L.p.$270
- Pfizer$214
- Incyte Corporation$178
- E.r. Squibb & Sons, L.L.C.$133
- plus $399 from 10 others
What the payments were for
- Consulting fees$2,97562%
- Speaking & faculty fees$4008%
- Food & beverage$1,46230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LEO Pharma Inc. | 5 | $3,165 |
| AbbVie(2 entities) | 5 | $477 |
| Galderma Laboratories, L.p. | 7 | $270 |
| Pfizer | 4 | $214 |
| Incyte Corporation | 2 | $178 |
| E.r. Squibb & Sons, L.L.C. | 5 | $133 |
| Novartis | 1 | $67 |
| Sanofi | 2 | $55 |
| Verrica Pharmaceuticals Inc. | 3 | $54 |
| Sun Pharmaceutical Industries Inc. | 2 | $49 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $41 |
| VYNE Pharmaceuticals Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Lilly USA, LLC | 1 | $24 |
| UCB, Inc. | 1 | $23 |
| Almirall LLC | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPZELURA$156
How this compares
$4,837 in reported general payments places this provider in the 65th percentile of 396 dermatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Ir-DrDoxycycline Monohydrate | 16 | $6,303 |
| Metronidazole | 95 | $5,531 |
| Ivermectin | 22 | $5,468 |
| Azelaic Acid | 28 | $4,050 |
| Ketoconazole | 161 | $2,719 |
| Tacrolimus | 21 | $2,567 |
| Fluorouracil | 35 | $2,286 |
| Clobetasol Propionate | 34 | $2,089 |
| Ciclopirox | 45 | $1,905 |
| Pimecrolimus | 12 | $1,869 |
| CiclopiroxCiclopirox Olamine | 13 | $1,300 |
| Econazole Nitrate | 28 | $1,220 |
| Fluocinonide | 46 | $1,216 |
| Doxycycline Hyclate | 45 | $1,193 |
| Triamcinolone Acetonide | 31 | $696 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Vienna
- Naiem IssaVienna$2M
- William SawchukVienna$36K
- Saurabh SinghFairfax$1.7M
- Diego DasilvaVirginia Beach$1.1M
- Vishal PatelLeesburg$719K
- Cyndi Torosky TommasoVirginia Beach$717K
- Daniel HurdBlacksburg$545K
- Jonathan SchreiberNorfolk$330K
- Robert BaerSuffolk$303K
- David PariserNorfolk$261K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.